Skip to main content
Publication

Investment in General Practice, 2012/13 to 2016/17, England, Wales, Northern Ireland and Scotland

This is part of

Official statistics
Publication date:
Geographic coverage:
United Kingdom
Geographical granularity:
Country
Date range:
01 Apr 2012 to 31 Mar 2017

Summary

This report details the investment in General Practice and the reimbursement for drugs dispensed in General Practices from 2012/13 to 2016/17.

The report draws on information obtained from country level financial monitoring reports discussed by the Technical Steering Committee (TSC), which is chaired by NHS Digital (the new trading name of the Health and Social Care Information Centre) and has representation from the UK Health Departments, NHS Employers, NHS England and the British Medical Association (BMA).

The data also contain some financial flows which do not reach GP practices, but contribute towards overall Primary Medical Care investment. These include Information Management and Technology (IM&T), some centrally-led or procured elements and funding invested in GP practice systems and Out of Hours services.

The report covers payments made to General Practices operating under GMS, PMS, APMS or Other (Non-GMS or PCTMS) contract types.

Key facts

For 2016/17, the total spend on General Practice including the reimbursement of drugs dispensed in General Practices was:

  • £10,203.9 million in England, compared to £9,696.6 million in 2015/16, an increase of 5.23 per cent
  • £511.3 million in Wales, compared to £ 488.3 million in 2015/16, an increase of 4.70 per cent
  • £275.6 million in Northern Ireland, compared to £ 266.8 million in 2015/16, an increase of 3.31 per cent
  • £861.9 million in Scotland, compared to £828.6 million in 2015/16, an increase of 4.01 per cent
  • £11,852.6 million in the UK as a whole, compared to £11,280.3 in 2015/16
    • this is an increase of 5.07 per cent, which in real terms is 3.02 per cent 

Resources

Related links

Last edited: 1 April 2019 1:52 pm